Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson Q3 2019 Earnings

      What you need to know about Johnson & Johnson’s 2019 third-quarter earnings

      Check out this infographic breakdown of the company’s third-quarter performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

      Share Article
      share to
      Inset - Quarterly Earnings Ribbon

      This morning, Johnson & Johnson shared its third-quarter performance.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “We delivered strong revenue and earnings growth during the third quarter, while also making strategic investments that advance our innovative pipeline across all three business segments,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Our colleagues around the world are passionate and committed to driving robust performance, while providing healthcare solutions that deliver long-term value to our patients, consumers, employees, communities and shareholders.”

      For more details about the company’s 2019 third-quarter results, and to read a comment from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


      UPDATED Johnson & Johnson Q3 2019 Earnings infographic

      Johnson & Johnson’s 2019 3rd-Quarter Earnings

      Read the earnings press release, which includes full financial details for the third quarter of the year.

      Want to see more company earnings information? Find several years of Johnson & Johnson’s quarterly and full-year results here.

      More from Johnson & Johnson

      Innovation
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      Health & wellness
       Blue latex gloved hand pointing at a brain MRI scan to pinpoint brain circuits associated with depression symptoms

      Is this the end of one-size-fits-all treatments for depression?

      Johnson & Johnson is working to bring personalized psychiatry to the 7 in 10 people with depression whose treatments aren’t getting the job done.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.